Quality of life 10 years after liver transplantation: The impact of graft histology

Table 1 Relationship between various parameters at the time of liver transplantation and the incidence of hepatic steatosis on 10-year post-liver transplantation biopsy

	All subjects n = 72	No HS n = 48	HS n = 24	P1
Age (yr)	35 ± 19	32 ± 21	42 ± 12	0.04
Gender (female)	52%	60%	71%	NS
Disease
Acute hepatic failure	24%	27%	17%	NS
Primary biliary cirrhosis	25%	25%	25%	NS
HBV-related cirrhosis	8%	6%	12%	NS
Autoimmune cirrhosis	7%	6%	8%	NS
Biliary atresia	5%	8%	0%	NS
HCV-related cirrhosis	12%	6%	25%	NS
Metabolic disease (Wilson disease)	1%	2%	0%	NS
Alcohol related cirrhosis	1%	2%	0%	NS
Primary sclerosing cholangitis	4%	4%	4%	NS
Cryptogenic cirrhosis	2%	4%	0%	NS
Hepatocellular carcinoma	8%	8%	8%	NS
ABO compatible	97%	96%	100%	NS
Donor age (years)	27 ± 11	27 ± 12	27 ± 10	NS
Donor gender (female)	41%	42%	39%	NS
Urgency	25%	27%	21%	NS
Cold ischemic time (min)	410 ± 212	406 ± 215	429 ± 214	NS
Reperfusion biopsy2
Steatosis (≥ 10%)	18%	15%	22%	NS
% of steatosis	24 ± 15	31 ± 16	16 ± 8	NS
Reperfusion lesions
Mild	26%	31%	17%	NS
Moderate to severe	60%	50%	79%	NS

Continuous data are represented as mean ± SD, and categorical data as percentage.

¹Comparison between HS and No HS;

²Reperfusion biopsy not done in 10 cases (9 in Non HS group and 1 in HS group). HS: Hepatic steatosis; NS: Not significant; HCV: Hepatitis C virus.